WC
NUVB icon

Wexford Capital’s Nuvation Bio NUVB Stock Holding History

Wexford Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772K Buy
135,889
+15,000
+12% +$73.3K 0.1% 75
2026
Q1 		$519K Sell
120,889
-9,111
-7% -$50.8K 0.08% 79
2025
Q4 		$1.16M Buy
130,000
+99,672
+329% +$617K 0.22% 72
2025
Q3 		$112K Sell
30,328
-51,262
-63% -$140K 0.02% 221
2025
Q2 		$159K Sell
81,590
-691,329
-89% -$1.44M 0.04% 187
2025
Q1 		$1.36M Sell
772,919
-173,300
-18% -$394K 0.35% 59
2024
Q4 		$2.52M Buy
946,219
+294,452
+45% +$758K 0.4% 38
2024
Q3 		$1.49M Buy
651,767
+588,500
+930% +$1.79M 0.36% 53
2024
Q2 		$185K Buy
63,267
+37,982
+150% +$116K 0.05% 178
2024
Q1 		$92K Buy
25,285
+11,288
+81% +$21.7K 0.02% 206
2023
Q4 		$21.1K Sell
13,997
-25,105
-64% -$32.3K ﹤0.01% 192
2023
Q3 		$52.4K Buy
39,102
+13,402
+52% +$22.3K 0.01% 182
2023
Q2 		$46.3K Sell
25,700
-71,938
-74% -$122K 0.01% 189
2023
Q1 		$162K Buy
97,638
+74,638
+325% +$151K 0.03% 174
2022
Q4 		$44.2K Buy
+23,000
New +$46.5K 0.01% 129

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wexford Capital's NUVB Position: Q2 2026 in Review

Wexford Capital increased its Nuvation Bio (NUVB) stake by 12% in Q2 2026, buying an estimated $73.3K and bringing the position to 135,889 shares worth $772K. The position accounts for 0.1% of the portfolio, ranked #75.

Wexford Capital first reported a position in NUVB in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.52M in Q4 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Wexford Capital held 135,889 shares of Nuvation Bio worth $772K as of Q2 2026.
  • Wexford Capital bought 15,000 Nuvation Bio shares in Q2 2026, an estimated $73.3K.
  • Nuvation Bio made up 0.1% of Wexford Capital's portfolio in Q2 2026, its #75 holding.
  • Wexford Capital first reported a position in Nuvation Bio in Q4 2022 and has held it in 15 quarters since.
  • Wexford Capital's Nuvation Bio position peaked at $2.52M in Q4 2024.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Wexford Capital's 13F filing for Q2 2026, filed 14 Aug 2026.